|
|
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
Sébastien Bailly
,
Olivier Leroy
,
Philippe Montravers
,
Jean-Michel Constantin
,
Hervé Dupont
et al.
Journal articles
hal-01205360v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Suspicion de péritonite à Candida dans l’étude AMARCAND II : peut-on prédire les patients qui vont avoir une culture positive ?
Hervé Dupont
,
Philippe Montravers
,
Jean-Pierre Gangneux
,
Élie Azoulay
,
Jean-Michel Constantin
et al.
Journal articles
hal-01244999v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study
Philippe Montravers
,
Elie Kantor
,
Jean-Michel Constantin
,
Jean-Yves Lefrant
,
Thomas Lescot
et al.
Journal articles
hal-02407334v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pneumonies associées aux soins de réanimation* RFE commune SFAR–SRLF
M. Leone
,
L. Bouadma
,
B. Bouhemad
,
O. Brissaud
,
S. Dauger
et al.
Journal articles
hal-02507537v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units
P. Montravers
,
P.F. Perrigault
,
J.F. Timsit
,
J.P. Mira
,
O. Lortholary
et al.
Journal articles
hal-01808143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|